TrialThe Journal of clinical investigation2018

Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.

Irina A Zalenskaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.